▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #212 by analyst upside · 2026-10-11
RPID
Rapid Micro Biosystems, Inc.
Healthcare · Market Cap $45M · P/E 0x
ANALYST PRICE TARGET
+543.5%
implied upside to consensus target
Current Price $0.89
Consensus Target $5.75
Bull Target $8.0
Bear Target $3.0
Analysts Covering 4
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
4
Hold
0
Sell
0
52-Week Low $0.83
52-Week High $4.94
YTD Return -71.5%
FUNDAMENTALS
Market Cap $45M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-1.11
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $35M
Profit Margin -145.6%
52-WEEK RANGE
52-Week Low $0.83
52-Week High $4.94
Current Price $0.89
Bear Target $3.0
Bull Target $8.0
● Now $0.89 ● Target $5.75
TRADING DATA
Avg Volume 263K
YTD Return -71.5%
Analyst Count 4
Consensus Buy
Upside to Target +543.5%
Last Updated 2026-10-11

ANALYST SUMMARY

Rapid Micro Biosystems, Inc. (RPID) is currently trading at $0.89 with a Wall Street consensus price target of $5.75, implying potential upside of 543.5% over the next 12 months. 4 analysts currently cover RPID, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $8.0, while the most cautious has a target of $3.0.

RPID operates in the Healthcare sector with a market capitalisation of $45M. The stock is down 71.5% year-to-date and is currently trading near the lower end of its 52-week range of $0.83 – $4.94.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

VXRT +675.2%
Vaxart, Inc.
$105M · P/E 2.5x · Buy
NCEL +655.3%
NewcelX Ltd.
$18M · P/E 5.9x · Strong Buy
SPRO +316.7%
Spero Therapeutics, Inc.
$70M · P/E 8.6x · Buy
HIND +322.6%
Vyome Holdings, Inc.
$15M · P/E 1.2x · Buy
CCLD +266.7%
CareCloud, Inc.
$85M · P/E 33.3x · Strong Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for RPID, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Roth Capital ● Initiated
Buy 2026-09-29 Building track record
Keybanc - Reiterated
Overweight → Overweight 2026-05-29 Building track record
Lake Street - Reiterated
Buy → Buy 2026-05-22 27% win rate (11 calls)
Lake Street ● Initiated
Buy 2025-07-28 27% win rate (11 calls)
Keybanc ● Initiated
Overweight 2025-02-12 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
39
out of 100
Coverage depth
12/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →